期刊文献+

胃癌P-糖蛋白表达与生物学行为的关系 被引量:1

Correlation Between Biological Behavior and Expression of P-glycoprotein in Gastric Carcinoma
下载PDF
导出
摘要 目的 研究多药耐药蛋白P - gp在胃癌组织中的表达及意义。 方法 采用S -P免疫组织化学染色法检测了 6 5例原发性胃癌P - gp的表达。 结果 P - gp表达与胃癌的浸润深度和淋巴结转移情况无关 ,而与组织学类型有关 ,高分化腺癌明显高于粘液腺癌及印戒细胞癌 (P<0 .0 5 )。结论 P - Objective To understand the relationship between P-glycoprotein overexpression and its clinical significance. Methods We examined the expression of P-glycoprotein with immunohistochemical technique in 65 cases of gastric carcinoma samples. Results The positive expression of P-glycoprotein was closely related to its histological types, but there were no significant correlation between the expression of P-glycoprotein and its clinical stages.Conclusions The positive expression of P-glycoprotein could be as an important factor in drug resistance,and may be used as a marker for the prognosis of gastric carcinoma.
出处 《齐齐哈尔医学院学报》 2003年第10期1085-1086,共2页 Journal of Qiqihar Medical University
关键词 胃癌 P-糖蛋白 生物学行为 预后 术后化疗 S-P免疫组织化学染色法 耐药性 P-glycoprotein Gastric cancer Immunohistochemistry
  • 相关文献

参考文献7

  • 1张天泽 徐光炜.肿瘤学[M].天津:天津科学技术出版社,1996.1209.
  • 2张威,邹寿椿,赵大健,姜蔚,赵仲生,徐文娟.多药耐药相关基因在胃癌组织中的表达及意义[J].肿瘤学杂志,2002,8(2):76-78. 被引量:9
  • 3Yeh KH,Chen CL,Shun CT,et al. Relatively low expression of multidrug resistance- 1 (MDR- 1 ) and its possible clinical impliation in gastric cancer[J]. J Clin Gastroenterol, 1998, 26:274-278.
  • 4Ling V. P-glycoprotein and resistance to anticancer drugs Cancer,1992,60:2 062-2 066.
  • 5Pastan Gottesman MM. Multiple-drug resistance in humancancer[J]. N EngL J Med, 1987,316 : 1 388- 1 393.
  • 6Wallner J, Depisch D, Gsur A, et al. MDR- 1 gene expression and its clinical relevance in primary gastric carcinomas[J]. Cancer,1993,71:667-671.
  • 7Gurel S,Yerci O,Filiz G,et al. High expression of multidrug resistanee-1 (MDR)- 1 and its relationship with multiple prognostie gaetors in gastrie eareinomas in patients in Turkey[J]. J Int Med Res,1000,27:70-84.

二级参考文献8

  • 1Nooter K,Stoter G.Molecular mechanisms of multidrug resistance in cancer chemotherapy [ J ].Pathol Res Pract,1996,192(7) :768 - 780.
  • 2Lehne G.P-glycoprotein as a drug target in the treatment of nultidrug resistant cancer[J ] .Curr Drug Targets,2000,1(1):85-99.
  • 3Koshiyama M,Fujii H,Kinezaki M,et al.Correlation between Topo Ⅱ alpha expression and chemosensitivity testing for Topo Ⅱ -targeting drugs in gynaecological carcinonas[J].Anticancer Res,2001: 21 (2A): 905 - 910.
  • 4Furukawa T,Kubota T,Murata H,et al.Antitumor spectra of anthracyclines against gastric cancer tissues obtained from surgical specimens with reference to p-glycoprotein expression[J].J Surg Oncol,1998,69(3): 173 - 177.
  • 5Moden N,Abe S,Sutoh I,et al.Pognostic significance of the expression of metallothionein,glutathione-s-transferase-pi and p-glycoprotein in curatively resected gastric cancer [ J ].Oncology,1997,54:391 - 399.
  • 6Kellner,Hutchinson L,Seidel,et al.Decreased drug accumulation in a mitoxantrone-resistant gastric carcinoma cell line in the absence of p-glycoprotein[J] .Int J Cancer,1997,71:817- 824.
  • 7Kim R,Ohi Y,Inoue H,et al.Expression and relationship between topoisomerase Ⅰ and Ⅱ alpha genes in tumor and normal tissues in esophageal,gastric and colon cancers[J].Anticancer Res,1999,19(6B) :5393- 5398.
  • 8Kreisholt J ,Sorensen M ,Jensen PB ,et al .Immunohistochemical detection of DNA topoisomerase Ⅱ alpha,P-glycoprotein and multidrug resistance protein (MRP) in small cell and non-small cell lung cancer [J] .BrJ Cancer,1998,77(9): 1469 - 1473.

共引文献556

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部